0001320325-05-000003.txt : 20120703
0001320325-05-000003.hdr.sgml : 20120703
20050310124616
ACCESSION NUMBER: 0001320325-05-000003
CONFORMED SUBMISSION TYPE: SC 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20050310
DATE AS OF CHANGE: 20050310
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Gipson Thomas Livingston
CENTRAL INDEX KEY: 0001320325
FILING VALUES:
FORM TYPE: SC 13G
BUSINESS ADDRESS:
BUSINESS PHONE: 9198478500
MAIL ADDRESS:
STREET 1: 7340 SIX FORKS ROAD
CITY: RALEIGH
STATE: NC
ZIP: 27615
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON LIFE SCIENCES INC /DE
CENTRAL INDEX KEY: 0000094784
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870277826
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-07548
FILM NUMBER: 05671512
BUSINESS ADDRESS:
STREET 1: 20 NEWBURY STREET
STREET 2: 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6174250200
MAIL ADDRESS:
STREET 1: 20 NEWBURY STREET
STREET 2: 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: GREENWICH PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: STRATEGIC MEDICAL RESEARCH CORP /DE
DATE OF NAME CHANGE: 19790521
SC 13G
1
blsi13gtlgmarch05.txt
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________
OMB APPROVAL
OMB NUMBER: 3235-0145
Expires: December 31, 2005
Estimated average burden
hours per response....11
_____________________________
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
BOSTON LIFE SCIENCES, INC.
-----------------------------------------------------
(Name of Issuer)
COMMON STOCK
-----------------------------------------------------
(Title of Class of Securities)
100843705
-----------------------------------------------------
(CUSIP Number)
3/8/05
-----------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[] Rule 13d-1(b)
[X] Rule 13d-1(c)
[] Rule 13d-1(d)
----------
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 100843705
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON(S)
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON(S)
THOMAS L. GIPSON
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES OF AMERICA
--------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES 970,000
BENEFICIALLY --------------------------------------------------------------
OWNED BY 6. SHARED VOTING POWER
EACH 0 (see item 6)
REPORTING --------------------------------------------------------------
PERSON 7. SOLE DISPOSITIVE POWER
WITH 970,000
--------------------------------------------------------------
8. SHARED DISPOSITIVE POWER
0 (See Item 6)
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
970,000 (See Item 6)
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.4 % (see Item 6)
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
Item 1. (a) Name of Issuer:
BOSTON LIFE SCIENCES INC.
--------------------------------------------------------------
(b) Address of Issuer's Principal Executive Offices:
20 NEWBURY ST
BOSTON, MA 02116
--------------------------------------------------------------
Item 2. (a) Name of Person Filing:
THOMAS L. GIPSON
--------------------------------------------------------------
(b) Address of Principal Business Office, or if None, Residence:
C/O INGALLS & SNYDER LLC
61 BROADWAY, NEW YORK, NY 10006
--------------------------------------------------------------
(c) Citizenship:
USA
--------------------------------------------------------------
(d) Title of Class of Securities:
COMMON STOCK
--------------------------------------------------------------
(e) CUSIP Number:
100843705
--------------------------------------------------------------
Item 3. If this statement is filed pursuant to Rules 240.13d-(1), or
13d-2(b) or (c), check whether the person filing is a:
(a) [] Broker or Dealer registered under Section 15 of the
Act, (15 U.S.C 78o)
(b) [ ] Bank as defined in Section 3(a)(6) of the
Act, (15 U.S.C 78c)
(c) [ ] Insurance Company as defined in Section 3(a)(19) of
the Act, (15 U.S.C 78c)
(d) [ ] Investment Company registered under Section 8 of the
Investment Company Act of 1940 (15 U.S.C 80a-8)
(e) [] Investment Adviser in accordance with Section
240.13d-1(b)(1)(ii)(E)
(f) [ ] Employee Benefit Plan or endowment fund in accordance
to Section 240.13d-1(b)(ii)(F)
(g) [ ] A parent holding company or control person in
accordance with Section 240.13d-1(b)(1)(ii)(G)
(h) [ ] A savings associations as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C 1813)
(i) [ ] A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of
the Investment Company Act of 1940 (15 U.S.C 80a-3)
(j) [ ] Group, in accordance with Section 240.13d-1(b)(1)(ii)(J)
Item 4. Ownership.
(a) Amount beneficially owned: 970,000----------,
(b) Percent of class: 9.4 %----------------------,
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote
970,000--,
(ii) Shared power to vote or to direct the vote
0 ------,
(iii) Sole power to dispose or to direct the disposition of
970,000-----,
(iv) Shared power to dispose or to direct the disposition of
0------
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following [ ].
INAPPLICABLE
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
Shares reported under sole voting and sole dispositve authority include common
shares owned by Gipson and shares issuable in exchange for 50,000 BLSI
warrants which give him the right to a acquire one share per warrant
(on a pre-reverse-split basis) at a price of $2.15 until 03/01/07. Shares
reported under sole voting and sole dispositive authority include 200,000
shares owned by Gipson's spouse as to which he disclaims beneficial ownership.
All shares reported assume the exercise of all warrants owned by Gipson.
Item 7. Identification and Classification of the Subsidiary which Acquired
the Security Being Reported on By the Parent Holding Company.
INAPPLICABLE
Item 8. Identification and Classification of Members of the Group.
INAPPLICABLE
Item 9. Notice of Dissolution of Group.
INAPPLICABLE
Item 10. Certification.
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired and are held in the
ordinary course of business and were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
Signature.
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
Date: 3/10/05
BY:
/s/ THOMAS L. GIPSON
----------------------------------
(Signature)*
THOMAS L. GIPSON
----------------------------------
(Name/Title)